期刊
TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 24, 期 3, 页码 137-144出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2012.10.002
关键词
acyl-CoA synthetase; arachidonic acid; eicosanoids; macrophage; monocyte
资金
- National Institutes of Health [HL062887, H1092969, HL097365]
- Diabetes Research Center at the University of Washington [P30 DK017047]
Monocytes and macrophages respond to and govern inflammation by producing a plethora of inflammatory modulators, including cytokines, chemokines, and arachidonic acid (C20:4)-derived lipid mediators. One of the most prevalent inflammatory diseases is cardiovascular disease, caused by atherosclerosis, and accelerated by diabetes. Recent research has demonstrated that monocytes/macrophages from diabetic mice and humans with type 1 diabetes show upregulation of the enzyme, acyl-CoA synthetase 1 (ACSL1), which promotes C20:4 metabolism, and that ACSL1 inhibition selectively protects these cells from the inflammatory and proatherosclerotic effects of diabetes, in mice. Increased understanding of the role of ACSL1 and other culprits in monocytes/macrophages in inflammation and diabetes-accelerated atherosclerosis offers hope for new treatment strategies to combat diabetic vascular disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据